AFT PharmaceuticalsNZSE:AFT 95 Dividend Yield % is 0.64% as of Jul. 12, 2026, which is 42% above its 10-year median of 0.45. GuruFocus rates NZSE:AFT with a GF Score™ of 95/100 and a GF Value™ of NZ$4.18 (Fairly Valued). The stock has 4 warning signs investors should review. Among 516 Drug Manufacturers companies, AFT Pharmaceuticals ranks worse than 77.52% on this metric.
As of today (2026-07-12), the Trailing Annual Dividend Yield of AFT Pharmaceuticals is 0.64%.
Good Sign:
AFT Pharmaceuticals Ltd stock Dividend Yield % is close to 3-year high.
The historical rank and industry rank for AFT Pharmaceuticals's Dividend Yield % or its related term are showing as below:
NZSE:AFT'
s Dividend Yield % Range Over the Past 10 Years
Min: 0.32 Med: 0.45 Max: 0.64
Current: 0.64
During the past 11 years, the highest Dividend Yield of AFT Pharmaceuticals was 0.64%. The lowest was 0.32%. And the median was 0.45%.
NZSE:AFT's Dividend Yield % is ranked worse than 77.52% of 516
companies
in the Drug Manufacturers industry
Industry Median: 1.95
vs NZSE:AFT: 0.64
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
AFT Pharmaceuticals Dividend Yield % Related Terms
AFT Pharmaceuticals Dividend Yield % Historical Data
* Premium members only.
The historical data trend for AFT Pharmaceuticals's Dividend Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NZSE:AFT vs ZTS, UTHR, VTRS: Dividend Yield % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, AFT Pharmaceuticals's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
AFT Pharmaceuticals Dividend Yield % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, AFT Pharmaceuticals's Dividend Yield % distribution charts can be found below:
* The bar in red indicates where AFT Pharmaceuticals's Dividend Yield % falls into.
Dividend Yield measures how much a company pays out in dividends each year relative to its share price.
AFT Pharmaceuticals Recent Full-Year* Dividend History
Amount
Ex-date
Record Date
Pay Date
Type
Frequency
Forex Rate
NZD 0.025000
2026-06-18
2026-06-19
2026-07-03
Cash Dividend
annually
NZD:NZD 1.000000
* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.
AFT Pharmaceuticals's Trailing Annual Dividend Yield (%) for Today is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
AFT Pharmaceuticals (NZSE:AFT) has a Dividend Yield % of 0.64% as of Jul. 12, 2026. Dividend yield is the ratio of company dividends to the share price. View historical data on AFT Pharmaceuticals and its competitors. This is 42% above median its historical median of 0.45. Over the past decade, AFT Pharmaceuticals' Dividend Yield % has ranged from 0.32 to 0.64. According to the industry distribution chart, AFT Pharmaceuticals ranks #400 out of 516 companies in the Drug Manufacturers industry, placing it in the top 77.5%.
Is AFT Pharmaceuticals' Dividend Yield % too high?
AFT Pharmaceuticals' current Dividend Yield % of 0.64% is 42% above median its 10-year median of 0.45. Over the past 10 years, this metric has ranged from a low of 0.32 to a high of 0.64. The Drug Manufacturers industry median Dividend Yield % is 1.95. AFT Pharmaceuticals' value of 0.64% is 67.2% below this industry median. Based on the distribution chart, AFT Pharmaceuticals ranks #400 out of 516 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, AFT Pharmaceuticals has a GF Score™ of 95/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does AFT Pharmaceuticals' Dividend Yield % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, AFT Pharmaceuticals ranks #400 out of 516 companies for Dividend Yield %. This places AFT Pharmaceuticals in the lower half of its industry. The industry median Dividend Yield % is 1.95. AFT Pharmaceuticals' value of 0.64% is 67.2% below this benchmark. Historically, AFT Pharmaceuticals' own Dividend Yield % has ranged from 0.32 to 0.64 over the past decade. While the company's 10-year median is 0.45 vs. the industry median of 1.95, AFT Pharmaceuticals has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Yield % for a Drug Manufacturers company?
The median Dividend Yield % among Drug Manufacturers companies is 1.95, based on 516 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. AFT Pharmaceuticals's current Dividend Yield % of 0.64% is 67.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Yield % mean?
A high Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Dividend yield is the ratio of company dividends to the share price. View historical data on AFT Pharmaceuticals and its competitors. For the Drug Manufacturers industry, the median Dividend Yield % is 1.95 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. AFT Pharmaceuticals's current Dividend Yield % is 0.64%, which is 42% above median its own 10-year median of 0.45. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is AFT Pharmaceuticals stock overvalued right now?
Based on GuruFocus' analysis, AFT Pharmaceuticals (NZSE:AFT) is currently considered Fairly Valued. The stock's GF Value™ is NZ$4.18, compared to a current price of NZ$3.91 — trading 6.5% below its estimated fair value. The current Dividend Yield % is 0.64%, which is 42% above median its 10-year median of 0.45 and 67.2% below the Drug Manufacturers industry median of 1.95. AFT Pharmaceuticals' overall GF Score™ is 95/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Yield % calculated?
Dividend Yield % is calculated from a company's financial statements. For AFT Pharmaceuticals (NZSE:AFT), the current Dividend Yield % is 0.64% as of Jul. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is AFT Pharmaceuticals (NZSE:AFT) Overvalued in 2026?
Based on GuruFocus' analysis, AFT Pharmaceuticals stock appears to be undervalued.
The current stock price of NZ$3.91 is trading 6.5% below its estimated GF Value™ of NZ$4.18.
GuruFocus considers AFT Pharmaceuticals to be Fairly Valued.
Key valuation signals for NZSE:AFT:
Dividend Yield %: 0.64% (42% above median its 10-year median of 0.45)
GF Value™: NZ$4.18 vs. price of NZ$3.91 (6.5% below fair value)
Industry Position: 67.2% below the Drug Manufacturers median (#400 of 516)
No single metric tells the full story. See the NZSE:AFT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
AFT Pharmaceuticals Ltd is a pharmaceutical distributor and developer of pharmaceutical intellectual property. Some of the products of the organization are Maxigesic dose forms, Capsaicin creams, Crystaderm, Kiwisoothe, Micolette, and others. The group has four operating segments based on geographical location being Australia, New Zealand, Asia, and the Rest of the world. It generates the majority of the revenue from Australia, which includes the sales and distribution activity relating to the Australian market.
95GF Score
Get the complete analysis for NZSE:AFT
Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NZSE:AFT has been successfully added to your 
